Pronóstico del mercado europeo de tratamiento de hematuria hasta 2028: impacto de COVID-19 y análisis regional por tratamiento (fármacos, terapias y otros), indicación (infecciones del tracto urinario, cálculos renales, uretritis, cáncer de sangre, cálculos en la vejiga, cáncer de próstata, cistitis, traumatismos, ejercicio vigoroso, poliquistosis renal, endometriosis y menstruación), tipo (hematuria macroscópica, hematuria microscópica, hematuria idiopática y hematuria del corredor), usuario final (hospitales, clínicas y centros de cirugía ambulatoria, y otros)
Introducción al mercado
La hematuria es una afección médica en la que se encuentra presencia de sangre en la orina. . Generalmente, la orina no contiene glóbulos rojos y, por lo tanto, esto puede provocar problemas graves que también pueden causar cálculos renales, infecciones del tracto urinario y otras enfermedades hereditarias.
Además, la alta prevalencia de hematuria Se espera que las indicaciones asociadas refuercen el crecimiento del mercado durante el período previsto. Sin embargo, los casos no diagnosticados de indicaciones asociadas limitan el crecimiento del mercado europeo de tratamiento de la hematuria.
Varios pacientes han informado de lesión renal aguda (IRA) progresiva al ingreso y durante la hospitalización y síntomas leves de proteinuria para hematuria, que se asocian con resultados clínicos adversos en pacientes hospitalizados con COVID 19. Se informa que la proteinuria y la hematuria tienen una prevalencia aún mayor en COVID-19 que la IRA. Estudios retrospectivos en China han informado que la proteinuria y la hematuria están asociadas con la COVID-19 y con una mayor mortalidad. Además, según la base de datos COVID19 de la Asociación Europea del Riñón (ERACODA) establecida en marzo de 2020, aproximadamente el 25% de los pacientes con trasplante de riñón son diagnosticados con coronavirus. Por lo tanto, se espera que un aumento en los pacientes con COVID positivo tengan más probabilidades de recibir tratamiento para la enfermedad renal.
Descripción general y dinámica del mercado
Se prevé que el mercado europeo del tratamiento de la hematuria alcance los 313,8 millones de dólares en 2028, desde los 270,5 millones de dólares de 2021; Se prevé que crezca a una tasa compuesta anual del 2,1% de 2021 a 2028. La mayoría de los pacientes de la región prefieren los servicios de atención domiciliaria. Los dispositivos médicos portátiles y portátiles tienen un gran potencial para mejorar el tratamiento al permitir que los pacientes continúen con sus actividades diarias junto con el proceso de diálisis. Por ejemplo, la diálisis en el hogar ofrece una mayor flexibilidad con los horarios de trabajo y estilo de vida de los pacientes. Además, el procedimiento general de la hemodiálisis domiciliaria está mucho más simplificado en comparación con la diálisis tradicional. Por tanto, los dispositivos portátiles e implantables podrían brindar a los pacientes la libertad de trabajar y realizar sus actividades diarias durante el tratamiento. Es probable que estas alternativas terapéuticas avanzadas impulsen el mercado europeo del tratamiento de la hematuria en los próximos años.
Segmentos de mercado clave
En términos de tipo, el segmento de hematuria macroscópica representó la mayor proporción del mercado europeo de tratamiento de hematuria en 2020. En términos de tratamiento, el segmento de medicamentos representó la mayor proporción de el mercado europeo de tratamiento de hematuria en 2020. En términos de indicación, el segmento de infecciones del tracto urinario representó la mayor proporción del mercado europeo de tratamiento de hematuria en 2020. En términos de usuario final, el segmento de hospitales representó la mayor proporción del mercado europeo de tratamiento de hematuria mercado de tratamiento en 2020.
Principales fuentes y empresas enumeradas
< span>Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado del tratamiento de la hematuria en Europa son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos de los gobiernos nacionales y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd y Boehringer Ingelheim International GmbH.
Informe de razones para comprar
- Comprender el panorama del mercado europeo de tratamiento de hematuria e identificar los segmentos del mercado que es probable que garanticen un fuerte retorno
- Para comprender el panorama del mercado en constante cambio y mantenerse a la vanguardia de la competencia
- Para lograr de manera eficiente planificar fusiones, adquisiciones y acuerdos de asociación en el mercado europeo de tratamiento de hematuria identificando segmentos con las ventas probables más prometedoras
- Tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del mercado rendimiento de varios segmentos
- Para obtener una previsión de ingresos del mercado europeo de tratamiento de hematuria en función de varios segmentos para el período 2021-2028
SEGMENTACIÓN DEL MERCADO EUROPEO DE TRATAMIENTO DE HEMATURIA
Por Tratamiento
- Medicamentos
- Terapias
- Otros
Por indicación
- Infecciones del tracto urinario
- Cálculos renales
- Uretritis
- Cáncer de sangre
- Cálculos en la vejiga
- Cáncer de próstata
- Cistitis
- Trauma
- Ejercicio vigoroso
- Enfermedad renal poliquística
- Endometriosis
- Menstruación
Por Tipo
- Hematuria macroscópica
- Hematuria microscópica
- Hematuria idiopática
- < span>Hematuria de Jogger
Por usuario final
< ul>Por país
- Europa
- Alemania
- Reino Unido
- Francia
- España
- Italia
- Resto de Europa
Empresas mencionadas
- < span>AstraZeneca
- Compañía Bristol-Myers Squibb
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- < span>Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Hematuria Treatment Market – By Treatment
1.3.2 Europe Hematuria Treatment Market – By Indication
1.3.3 Europe Hematuria Treatment Market – By Type
1.3.4 Europe Hematuria Treatment Market – By End User
1.3.5 Europe Hematuria Treatment Market – By Country
2. Europe Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Europe Analysis
6.1 Europe Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Europe Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Europe Hematuria Treatment Market – Geographic Analysis
11.1 Europe: Hematuria Treatment Market
11.1.1 Overview
11.1.2 Europe: Hematuria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.4 Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.5 Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.6 Europe: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7 Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
11.1.7.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Germany: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.1.3 Germany: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.1.4 Germany: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.1.5 Germany: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 France: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.2.3 France: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.2.4 France: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.2.5 France: Hematuria Treatment Market, by End user, 2019–2028 (US$ Million)
11.1.7.3 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 UK: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.3.3 UK: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.3.4 UK: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.3.5 UK: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.4 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Italy: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.4.3 Italy: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.4.4 Italy: Hematuria Treatment Market, by Type, 2019-2028 (US$ Million)
11.1.7.4.5 Italy: Hematuria Treatment Market, by End User, 2019-2028 (US$ Million)
11.1.7.5 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.1 Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.5.2 Spain: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.5.3 Spain: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.5.4 Spain: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.5.5 Spain: Hematuria Treatment Market, by End User, 2019–2028 (US$ Million)
11.1.7.6 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.1 Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.6.2 Rest of Europe: Hematuria Treatment Market, By Treatment, 2019–2028 (US$ Million)
11.1.7.6.3 Rest of Europe: Hematuria Treatment Market, By Indication, 2019–2028 (US$ Million)
11.1.7.6.4 Rest of Europe: Hematuria Treatment Market, by Type, 2019–2028 (US$ Million)
11.1.7.6.5 Rest of Europe: Hematuria Treatment Market, By End User, 2019–2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 2. Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 3. Europe Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. Europe Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Germany: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Hematuria Treatment Market, by End user – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 14. UK: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 22. Spain: Hematuria Treatment Market, By Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. Spain: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Spain: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe: Hematuria Treatment Market, By Treatment – Revenue and Forecast to 2028 (US$ Million)
Table 26. Rest of Europe: Hematuria Treatment Market, By Indication– Revenue and Forecast to 2028 (US$ Million)
Table 27. Rest of Europe: Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (US$ Million)
Table 28. Rest of Europe: Hematuria Treatment Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. Organic Developments Done by Companies
Table 30. Inorganic Developments Done by Companies
Table 31. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Europe Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UK to Show Significant Growth During Forecast Period
Figure 5. Europe Hematuria Treatment Market, Industry Landscape
Figure 6. Europe PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Europe Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Europe Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Europe Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Europe Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Europe: Hematuria Treatment Market, by Key Country – Revenue (2021) (US$ Million)
Figure 37. Europe Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe: Hematuria Treatment Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. France: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. UK: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Italy: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Spain: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Rest of Europe: Hematuria Treatment Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Impact Of COVID-19 Pandemic in Europe Country Markets
Figure 46. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.